✦ LIBER ✦

The Safety of Home Therapy with Subcutaneous Anti-Immunoglobulin E Antibody Omalizumab in Twenty-five Patients with Allergic Asthma

✍ Scribed by Liebhaber, M.I.; Dyer, Z.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety of anti-immunoglobulin E therapy

✍ A. A. Cruz; F. Lima; E. Sarinho; G. Ayre; C. Martin; H. Fox; P. J. Cooper 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB

Efficacy and tolerability of anti-immuno

✍ A. M. Vignola; M. Humbert; J. Bousquet; L-P. Boulet; S. Hedgecock; M. Blogg; H. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 241 KB

Efficacy and safety of a recombinant ant

✍ S. T. Holgate; A. G. Chuchalin; J. Hébert; J. Lötvall; G. B. Persson; K. F. Chun 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB

Efficacy and tolerability of anti-immuno

✍ J. G. Ayres; B. Higgins; E. R. Chilvers; G. Ayre; M. Blogg; H. Fox 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 226 KB

Evaluation of long-term safety of the an

✍ Berger, William; Gupta, Niroo; McAlary, Margaret; Fowler-Taylor, Angel 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 226 KB

THE SAFETY OF OMALIZUMAB THERAPY IN A PA

✍ Antonicelli, Leonardo; Stagnozzi, Giorgia; Giuliodoro, Simona; Abbruzzetti, Ales 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 60 KB